Summary
Normal immune responsiveness is compared with four main types of experimental lymphomagenesis. In these types of lymphoma, the proximal cause of lymphomagenesis can be identified as a specific class of the immunoregulatory defect. The adaptive differentiation of normal immunocytes to immunocompetence permits the specific activation by antigenic determinants through the requirement for cognate recognition of such epitopes in the presenic determinants maintained self-tolerant state. Defective control of immune responsiveness in lymphomagenesis permits lymphocyte activation by stimuli resulting from the acquisition of alterations or defects in the expression of normally invariant molecules present during adaptive differentiation. Target antigens include class I and II MHC, env glycoproteins, and framework determinants of T cell receptor or immunoglobulin idiotype. Features common to both normal immune responsiveness and to lymphomagenesis are immunocompetence of the cognate recognition process and specificity of the target immunocyte for the permitted immunogenic or lymphomagenic stimulus.
References
Ada G. L.: Antigen recognition by lymphoid cells. A cell surface phenomenon. In:Bolis L., Katchalsky A., Keynes R. D., Lowenstein W. R., Pethica B. A. (Eds): Permeability and function of biological membranes. North-Holland Publ. Co., Amsterdam, 1970; p. 129.
Adams J. M., Kemp D. J., Bernard O., Gough N., Webb R. E., Tyler B., Gerondakis S., Cory S.: Organisation and expression of murine immunoglobulin genes — Immunol. Rev.59, 5, 1981.
Adler L. T.: Escape from allotype suppression. In:Bona C., Cazenave P.-A. (Eds): Lymphocytic regulation by antibodies. John Wiley and Sons, New York, 1981; p. 1957.
Adorini L., Pini C., De Santis R., Robbiati F., Doria G., Riccardi-Castagnou P.: Monoclonal suppressor T factor displaying VH restriction and fine antigenic specificity — Nature (Lond.)303, 704, 1983.
Arnold L. W., Pennell C. A., Locasio N. J., Haughton G.: Cross-reactive idiotypes of murine B cell lymphomas: implications for aetiology and immunotherapy. In:Vitetta E. S. (Ed.): B and T cell tumours. Academic Press, New York, 1982; p. 499.
Auffray C., Kuo J., DeMars R., Strominger J. L.: A minimum of four human class II α chains are encoded in the HLA chromosome region of chromosome 6 — Nature (Lond.)304, 174, 1983.
Augustin A. A., Sim G. K., Bona C.: Internal images within the immune network — Surv. immunol. Res.2, 78, 1983.
Baird S. M., Raschke W. C.: Murine T lymphoma ‘immunoglobulin’ is identical to leukaemia virus GP70 — Molec. Immunol.19, 1045, 1982.
Benacerraf B., McDevitt H. L.: Histocompatibility-linked immune response genes — Science175, 273, 1972.
Bentley D. L.: Most K immunoglobulin mRNA in human lymphocytes is homologous to a small family of germline K genes — Nature (Lond.)307, 77, 1984.
Bernards R., Schrier P. I., Houweling A., Bos J. L., van der Eb A. J., Zijlstra M., Melief C. J. M.: Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T cell immunity — Nature (Lond.)305, 776, 1983.
Binz H., Wigzell H.: Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes in IgG molecules and T-cell receptors with specificity for the same alloantigens — J. exp. Med.142, 197, 1975.
Blattner F. R., Tucker P. W.: The molecular biology of immunoglobulin D — Nature (Lond.)307, 417, 1984.
Bona C. A.: Parallel sets and the internal image of antigen within the idiotypic network — Fed. Proc.43, 2558, 1984.
Bona C. A., Paul W. E.: Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype — J. exp. Med.149, 592, 1979.
Brown P. H., Mathis D., Cone R. E., Jones P. P., Ponzio N. M., Thorbecke G. J.: Properties of reticulum cell sarcomas in SJL/J mice. VIII. Prominent role of RCS cell IA antigens in the stimulation of syngeneic T cells — Immunogenetics18, 399, 1983.
Cantor H., Boyse E. A.: Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity — J. exp. Med.141, 1390, 1975.
Cazenave P.-A.: Idiotypy of antibodies. In:Bona C., Cazenave P. A. (Eds): Lymphocytic regulation by antibodies. John Wiley and Sons, New York, 1981; p. 171.
Chang H.-C., Moriuchi T., Silver J.: The heavy chain of human B alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region — Nature (Lond.)350, 813, 1983.
Chien Y.-L., Becker D. M., Lindsten T., Okamura M., Cohen D. I., Davis M. M.: A third type of murine T-cell receptor gene — Nature (Lond.)312, 31, 1984.
Claman H. N., Chaperon E. A., Triplett R. F.: Thymus-marrow cell combination: synergism in antibody production — Proc. Soc. exp. Biol. (N.Y.)122, 1167, 1966.
Cohen I. R., Wekerle H.: Regulation of autosensitisation. The immune activation and specific inhibition of self-recognising thymus-derived lymphocytes — J. exp. Med.137, 224, 1973.
Cohn M.: The T-cell receptor mediating restrictive recognition of antigen — Cell33, 657, 1983.
Cory S.: Oncogenes and B lymphocyte neoplasia — Immunol. Today4, 205, 1983.
Coutinho A., Forni L., Bernabe R. R.: The polyclonal expression of immunoglobulin variable region determinants on the membrane of B cells and their precursors — Springer’s Semin. Immunopathol.3, 171, 1980.
Coutinho A., Forni L., Holmberg D., Ivars F., Vaz N.: From an antigen-centred clonal perspective of immune responses to an organism-centred network perspective of autonomous activity in a self-referential immune system — Immunol. Rev.79, 151, 1984.
Doherty P. C.: Immunological surveillance: T cell repertoire and the biological function of MHC antigens. In:Moller E., Moller G. (Eds): Genetics of the immune response. Nobel Foundation Symposium. Plenum Press, New York, 1983; p. 91.
Dorf M. E.: Genetic control of immune responsiveness. In:Dorf M. E. (Ed.): The role of the major histocompatibility complex in immunobiology. John Wiley and Sons, New York, 1981; p. 221.
East J.: Immunopathology and neoplasms in New Zealand Black (NZB) and SJL/J mice — Progr. exp. Tumor Res. (Basel)13, 84, 1970.
Ertl H. J. C., Greene M. I., Noseworthy J. H., Fields B. N., Nepom J. T., Spriggs D. R., Finberg R. W.: Identification of idiotypic receptors on reovirus-specific cytolytic T cells — Proc. nat. Acad. Sci. (Wash.)79, 7479, 1982.
Famulari N. G.: Murine leukaemia viruses with recombinant ENV genes. A discussion of their role in leukaemogenesis — Curr. Top. Microbiol. Immunol.103, 76, 1983.
Feinstein A.: Immunoglobulins and histocompatibility antigens — Nature (Lond.)282, 230, 1979.
Flaherty L.: TLA region antigens. In:Dorf M. E. (Ed.): The role of the major histocompatibility complex in immunobiology. John Wiley and Sons, New York, 1981; p. 33.
Flood P. M., Deleo A. B., Old L. J., Gershon R. K.: Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules — Proc. nat. Acad. Sci. (Wash.)80, 1683, 1983.
Forni L., Cazenave P.-A., Cosenza H., Forsbeck K., Coutinho A.: Expression of V region-like determinants on Ig negative B cell precursors in murine foetal liver and marrow — Nature (Lond.)280, 241, 1979.
Frelinger J., Sing A., Infante A., Fathman C. G.: Clonotypic antibodies which stimulate T cell clonal proliferation — Immunol. Rev.81, 21, 1984.
Frikke M. J., Bridges S. H., Lynch R. C.: Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity — J. Immunol.118, 2206, 1977.
Gleichmann E., Gleichmann H., Schwartz R. S.: Immunological induction of malignant lymphoma: genetic factors in the graft-versus-host model — J. nat. Cancer Inst.49, 793, 1976.
Gotze H., Kratzin H., Thinnes F. P., Yang C.-Y., Kruse T., Pauly E., Kolbel S., Egert G., Wernet P., Hilschmann N.: Primary structure of human class II histocompatibility antigens. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA A 3.3, B 7.7, DW 2.2, DR 2.2, MT 1.1, DC 1.1, MB 1.1) — Hoppe-Seylers Z. physiol. Chem.364, 749, 1983.
Gozes Y., Umiel T., Meshorer A., Trainin N.: Syngeneic G.V.H. induced in popliteal lymph nodes by spleen cells of old C57BL/6 mice — J. Immunol.121, 2199, 1978.
Greaves M. F., Delia D., Robinson J., Sutherland R., Newman R.: Exploitation of monoclonal antibodies: a ‘who’s who’ of haematopoietic malignancy — Blood Cells7, 257, 1981.
Greaves M. F., Verbi W., Festenstein H., Papasteriadis C., Jaraquemada D., Hayward A.: ‘Ia-like’ antigens on human T cells — Europ. J. Immunol.9, 356, 1979.
Gross L.: The search for viruses as etiological agents in leukaemia and malignant lymphomas: the role of the happy accident and the prepared mind — Cancer Res.40, 3405, 1980.
Hanjo T., Nakai S., Nishida Y., Karaoka T., Yamawaki-Kataoka Y., Takahashi N., Obata M., Shimizu A., Yaoita Y., Nikaido T., Ishada N.: Rearrangement of immunoglobulin genes during differentiation and evolution — Immunol. Rev.59, 33, 1981.
Hannum C. H., Kappler J. W., Trowbridge I. S., Marrack P., Freed J. H.: Immunoglobulin-like nature of the α-chain of a human T-cell antigen/MHC receptor — Nature (Lond.)312, 65, 1984.
Hiernaux J., Bona C.: Immune network. In:Bona C., Cazenave P.-A. (Eds): Lymphocytic regulation by antibodies. John Wiley and Sons, New York, 1981; p. 269.
Holmberg D., Forsgren S., Forni L., Ivars F., Coutinho A.: Idiotypic determinants on natural IgM antibodies that resemble self Ia antigens — Proc. nat. Acad. Sci. (Wash.)81, 3175, 1984.
Holmberg D., Ivars F., Coutinho A.: Reactions amongst IgM antibodies isolated from newborn mice — Europ. J. Immunol.14, 435, 1984.
Hood L., Steinmetz M., Malissen B.: Genes of the major histocompatibility complex of the mouse — Ann. Rev. Immunol.1, 529, 1983.
Howard M., Nakanishi K., Paul W. E.: B cell growth and differentiation factors — Immunol. Rev.78, 185, 1984.
Inba K., Witmer M. D., Steinman R. M.: Clustering of dendritic cells, helper T lymphocytes and histocompatible B cells during primary antibody responsesin vitro — J. exp. Med.160, 858, 1984.
Janeway C. A., Sakato N., Eisen H. N.: Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes — Proc. nat. Acad. Sci. (Wash.)72, 2357, 1975.
Jerne N. K.: Towards a network theory of the immune system — Ann. Immunol. (Inst. Pasteur)125C, 373, 1974.
Jerne N. K.: Idiotypic networks and other preconceived ideas — Immunol. Rev.79, 1, 1984.
Johnson D. L., Kettman J. R.: Accessory cell restrictions onin vitro growth of a T cell lymphoma. Residual antigen recognition related to the lymphomagenesis process. In:Vitetta E. S. (Ed.): B and T cell tumours. Academic Press, New York, 1982; p. 310.
Julius M. H., Augustin A. A., Cosenza H.: Recognition of a naturally occurring idiotype by autologous T cells — Nature (Lond.)256, 251, 1977.
Juy D., Primi D., Sanchez P., Cazenave P.-A.: The selection and maintenance of the V region determinant repertoire is germline-encoded and T cell-independent — Europ. J. Immunol.13, 326, 1983.
Kaartinen M., Griffiths G. M., Markham A. F., Milstein C. P.: M-RNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification — Nature (Lond.)304, 320, 1983.
Katz D. H.: The allogeneic effect on immune responses. In:Katz D. H. (Ed.): Lymphocyte differentiation, recognition and regulation. Academic Press, New York, 1977; p. 485.
Katz D. H.: Adaptive differentiation of lymphocytes: theoretical implications for mechanisms of cell-cell recognition and regulation of immune responses — Advanc. Immunol.29, 138, 1980.
Katz D. H., Hamaoka T., Dorf M. E., Maurer P. H., Benacerraf B.: Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of the immune response (Ir) gene in the control of lymphocyte interactions in responses controlled by this gene — J. exp. Med.138, 734, 1973.
Katz D. H., Zuberi R. I.: Cell interaction (CI) and anti-CI molecules: experiments and concepts on cell/cell interactions in the immune system — Ann. Immunol. (Inst. Pasteur)135D, 95, 1984.
Katz I. R., Asofsky R., Thorbecke G. J.: Suppression of spontaneous reticulum cell sarcoma development and of syngeneic stimulator cells by anti-μ treatment of SJL/J mice — J. Immunol.125, 1355, 1980.
Kearney J. F., Cooper M. D., Lawton A. R.: B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies — J. Immunol.116, 1664, 1976.
Kearney J. F., Klein J., Bockman D. E., Cooper M. D., Lawton A. R.: B cell differentiation induced by lipopolysaccharide. V. Suppression of plasma cell maturation by anti-µ. Mode of action and characteristics of suppressed cells — J. Immunol.120, 158, 1978.
Kehrl J. H., Muraguchi A., Butler J. L., Falkoff R. J. M., Fauci A. S.: Human B cell activation, proliferation and differentiation — Immunol. Rev.78, 75, 1984.
Kindt T. J., Coutinho A.: More sources of antibody diversity — Nature (Lond.)304, 306, 1983.
Klein J., Figueroa F., Nagy Z. A.: Genetics of the major histocompatibility complex: the final act — Ann. Rev. Immunol.1, 119, 1983.
Komuro K., Boyse E. A., Old L. J.: Production of TL antibody by mice immunised with TL populations — J. exp. Med.137, 533, 1973.
Kontiris T. G.: The emerging genetics of human cancer — New Engl. J. Med.309, 404, 1983.
Lanier L. L., Babcock G. F., Lynes M. A., Haughton G.: Antigen-induced murine B cell lymphomas. III. Passive anti-idiotypic serum therapy and its combined effect with chemotherapy — J. nat. Cancer Inst.63, 1417, 1979.
Lee M. S., Horng W. J., Gilman-Sachs A., Dray S.: The common idiotypic specificity of anti-a2 allotype antibodies. Contribution of H and L chains to idiotype expression — Molec. Immunol.20, 557, 1983.
Lennox E. S., Lowe A. D., Cohn J., Evan G.: Specific antigens on methylcholanthrene-induced tumours of mice — Transplant. Proc.13, 1759, 1981.
Lerman S. P., Chapman J. M., Carswell E. A., Thorbecke G. J.: Properties of reticulum cell sarcomas in SJL/J mice. I. Proliferative response to tumour cells of T-derived lymphoid cells from normal mice — Int. J. Cancer14, 808, 1974.
Lerman S. P., Carswell E. A., Chapman J. M., Thorbecke G. J.: Properties of reticulum cell sarcomas in SJL/J mice. III. Promotion of tumour growth in irradiated mice by normal lymphoid cells — Cell. Immunol.23, 53, 1976.
Mak T. W., Yanagi Y.: Genes encoding the human T cell antigen receptor — Immunol. Rev.81, 221, 1984.
Makgoba M. W., Fuggle S. V., McMichael A. J., Morris P. J.: HLA-DR products are a subset of human Ia antigens — Nature (Lond.)301, 531, 1983.
Marchalonis J. J., Vasta G. R., Warr G. W., Barker W. C.: Probing the boundaries of the extended immunoglobulin family of recognition molecules: jumping domains, convergence, and minigenes — Immunol. Today5, 133, 1984.
Margolies M. N., Wysocki L. J., Sato V. L.: Immunoglobulin idiotype and anti-antiidiotype utilise the same variable region genes irrespective of antigen specificity — J. Immunol.130, 515, 1983.
Martinez A.-C., Pereira P., Bernabe R., Bandeira A., Larsson E.-L., Cazenave P.-A., Coutinho A.: Internal complementarities in the immune system: regulation of the expression of helper T-cell idiotypes — Proc. nat. Acad. Sci. (Wash.)81, 4520, 1984.
McGrath M. S., Jerabek L., Weissman I. L.: Receptor-mediated leukaemogenesis: retrovirus receptors on B and T lymphomas share idiotypic determinants. In:Baum S. J., Ledney G. D., Thierfelder S. (Eds): Experimental hematology today. Karger, Basel, 1982; p. 93.
McNamara M., Kohler H.: Regulatory idiotypes. Induction of idiotype-recognising helper T cells by free light and heavy chains — J. exp. Med.159, 623, 1984.
Metcalf D., Wiadrowsky M., Bradley R.: Analysis of the role of the thymus in leukaemia development with the use of thymectomy and thymus grafts — Nat. Cancer Inst. Monogr.22, 571, 1966.
Milburn G. L., Hoover R. G., Lynch R. G.: Immunoregulatory cell interactions that govern the growth and differentiation of murine myeloma cells. In:Vitetta E. S. (Ed.): B and T cell tumours. Academic Press, New York, 1982; p. 335.
Murphy E. D.: SJL/J: a new inbred strain of mice with high early incidence of reticulum cell neoplasms — Proc. Amer. Ass. Cancer Res.4, 46, 1963.
Niman H. L., Elder J. H.: M Abs as probes of protein structure: molecular diversity among the envelope glycoproteins (gp70s) of the murine retroviruses. In:Katz D. H. (Ed.): Monoclonal antibodies and T cell products. CRC Press Inc., Boca Raton, Fla, 1982; p. 23.
Orr H. T., Lancet D., Robb R. J., Lopez de Castro J., Strominger J. L.: The heavy chain of human histocompatibility antigen HLA-B7 contains an immunoglobulin-like region — Nature (Lond.)282, 266, 1979.
Owens M. H., Bonavida B.: Immune functions characteristic of SJL/J mice and their association with age and spontaneous reticulum cell sarcoma — Cancer Res.36, 1077, 1976.
Patten P., Yokota T., Rothbard J., Chien Y.-L., Arai K.-I., Davis M. M.: Structure, expression and divergence of T-cell receptor β-chain variable regions — Nature (Lond.)312, 40, 1984.
Pernis B., Mitchison N. A.: Workshop summary: network control of B cell activity. In:Janeway C., Sercarz E. E., Wigzell H. (Eds): Immunoglobulin idiotypes. Academic Press, New York, 1981; p. 799.
Pike B. L., Boyd A. W., Nossal G. J. V.: Clonal anergy: the universally anergic B lymphocyte — Proc. nat. Acad. Sci. (Wash.)79, 2013, 1982.
Potter M., Robertson C. L.: Development of plasma cell neoplasms in Balb/C mice after intraperitoneal injection of paraffin-oil adjuvant, heat-killed staphylococcal mixtures — J. nat. Cancer Inst.25, 847, 1960.
Primi D., Goodman J. W., Lewis G. K.: Idiotype-specific T cell help in the anti-arsonate response of A/J mice. In:Janeway C., Sercarz E. E., Wigzell H. (Eds): Immunoglobulin idiotypes. Academic Press, New York, 1981; p. 547.
Rabbitts T. H., Bentley D. L., Milstein C. P.: Human antibody genes: V gene variability and CH gene switching strategies — Immunol. Rev.59, 69, 1981.
Raff M. C., Owen J. J. T., Cooper M. D., Lawton A. R., Megson M., Gathings W. E.: Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin suppressionin vitro — J. exp. Med.142, 1052, 1975.
Rajewsky K., Takemori T.: Genetics, expression and function of idiotypes — Ann. Rev. Immunol.1, 569, 1983.
Ratcliffe M. J. H., Mitchison N. A.: Function of Ig receptors in B-cell triggering — Ann. Immunol. (Inst. Pasteur)135D, 73, 1984.
Reinisch C. L., Sing A. P., Waldron J. A., Kemp J. D.: Isolation of malignant and functional Ly1+ T-cell clones from B-cell lymphoma — Nature (Lond.)298, 176, 1982.
Rocca-Serra J., Tonnelle C., Fougereau M.: Two monoclonal antibodies against different antigens using the same VH germline gene — Nature (Lond.)304, 353, 1983.
Rodkey L. S., Adler F. L.: Regulation of natural anti-allotype antibody responses by idiotype network-induced auto-anti-idiotypic antibodies — J. exp. Med.157, 1920, 1983.
Ruff J., Tonnelle C., Rocca-Serra J., Moinier D., Pierres M., Ju S., Dorf M. E., Theze J., Fougereau M.: Structural basis for public idiotypic specificities of monoclonal antibodies directed against poly (Glu60-Ala30-Tyr10) and poly (Glu60-Ala60) random copolymers — Proc. nat. Acad. Sci. (Wash.)80, 3040, 1983.
Saito H., Kranz D. M., Takagaki Y., Hayday A. C., Eisen H. N., Tonegawa S.: A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes — Nature (Lond.)312, 36, 1984.
Schrier P. I., Bernards R., Vaessen R. J. M. J., Houweling A., van der Eb A. J.: Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells — Nature (Lond.)305, 771, 1983.
Sell S., Gell G.: Studies on rabbit lymphocytesin vitro. I. Stimulation of blast transformation with an anti-allotype serum — J. exp. Med.122, 423, 1965.
Sercarz E.: High connectivity within the network — Immunol. Today5, 348, 1984.
Shaw S., DeMars R., Schlossman S. F., Smith P. L., Lampson L. A., Nadler L. M.: Serological identification of human secondary B cell (SB) antigens. Correlations between functions, genetics and structure — J. exp. Med.156, 731, 1982.
Sidman C. L., Unanue E. R.: Receptor-mediated inactivation of early B lymphocytes — Nature (Lond.)257, 149, 1975.
Sidman C. L., Unanue E. R.: Control of B lymphocyte function. I. Inactivation of mitogenesis by interaction with surface immunoglobulin and Fc receptor molecules — J. exp. Med.144, 882, 1976.
Sigal N. H., Klinman N. R.: The B-cell clonotype repertoire — Advanc. Immunol.26, 255, 1978.
Silver J., Ferrone S.: Structural polymorphism of human DR antigens — Nature (Lond.)279, 436, 1979.
Stockert E., Boyse E. A., Obata Y., Ikeda H., Sarkar N. H., Hoffman H. A.: New mutant and congenic mouse stocks expressing the murine leukaemia virus-associated thymocyte surface antigen GIX — J. exp. Med.142, 512, 1975.
Stockert E., Old L. J., Boyse E. A.: The GIX system. A cell surface alloantigen associated with murine leukaemia virus: implications regarding chromosome integration of the viral genome — J. exp. Med.133, 1334, 1971.
Sy M.-S., Lowy A., Hayglass K., Janeway C. A., Gurish M., Greene M. I., Benacerraf B.: Chronic treatment with rabbit anti-mouse µ-chain antibody alters the characteristic immunoglobulin heavy chain restriction of murine suppressor T-cell factors — Proc. nat. Acad. Sci. (Wash.)81, 3846, 1984.
Takemori T., Rajewsky K.: Mechanism of neonatally induced idiotype suppression and its relevance for the acquisition of self-tolerance — Immunol. Rev.79, 103, 1984.
Teillaud J.-L., Desaymard C., Giustri A. M., Haseltine B., Pollock R. R., Yelton D. E., Zack D. J., Scharff M. D.: Monoclonal antibodies reveal the structural basis of antibody diversity — Science222, 721, 1983.
Tesch H., Takemori T., Rajewsky K.: The immune response against anti-idiotype antibodies. II. The induction of antibodies bearing the target idiotype (Ab3) depends on the frequency of the corresponding B cells — Europ. J. Immunol.13, 726, 1983.
Tonegawa S.: Somatic generation of antibody diversity — Nature (Lond.)302, 575, 1983.
Travers P., Blundell T. L., Sternberg M. J. E., Bodmer W. F.: Structural and evolutionary analysis of HLA-D region products — Nature (Lond.)310, 235, 1984.
Tung J.-S., Fleissner E., Vitetta E. S., Boyse E. A.: Expression of murine leukaemia virus envelope glycoprotein gp 69/71 on mouse thymocytes. Evidence for two structural variants distinguished by presencevs. absence of GIX antigen — J. exp. Med.142, 518, 1975.
Urbain J., Wuilmart C.: Some thoughts on idiotypic networks and immunoregulation — Immunol. Today3, 86 and 125, 1982.
Wallis V. J., Chaudhuri M., Jacob M. C., Valkova B. A., Davies A. J. S.: Neoplasms arising in CBA mice after transfer of spleen cells from syngeneic old donors — Immunology53, 769, 1984.
Warr G. W., Vasta G. R., Ledford B. E., Marchalonis J. J.: Evidence for the existence of a diverse family of immunoglobulin-related recognition molecules — J. Immunogenet.10, 17, 1983.
Watanabe M. R., Aldo-Benson M. A.: Specific suppression of hybridoma immunoglobulin secretion by haptene-conjugated mouse IgG: a model of B cell tolerance — Cell. Immunol.9, 345, 1983.
Watson A. J., DeMars R., Trowbridge I. S., Bach F. H.: Detection of a novel human class II HLA antigen — Nature (Lond.)304, 358, 1983.
Weiss R. A., Marshall C. J.: DNA in medicine: oncogenes — Lancetii, 1138, 1984.
Wickler M., Demeur C., Dewasme G., Urbain J.: Immunoregulatory role of maternal idiotypes. Ontogeny of immune networks — J. exp. Med.152, 1024, 1980.
Woodruff M. F.: Cellular heterogeneity in tumours — Brit. J. Cancer47, 589, 1983.
Yancopoulos G. D., Desiderio S. V., Paskind M., Kearney J. F., Baltimore D., Alt F. W.: Preferential utilization of the most J-H-proximal VH gene segments in pre-B-cell lines — Nature (Lond.)311, 727, 1984.
Yoshizaki K., Nakagawa T., Fukunaga K., Kaieda T., Maruyama S., Kishimoto S., Yamamura Y., Kishimoto T.: Characterisation of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells — J. Immunol.130, 1241, 1983.
Zanders E. D., Lamb J. R., Feldmann M., Green N., Beverley P. C.: Tolerance of T-cell clones is associated with membrane antigen changes — Nature (Lond.)303, 625, 1983.
Zinkernagel R. M., Doherty P. C.: MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic transplantation antigens determining T-cell restriction specificity, function and responsiveness — Advanc. Immunol.27, 51, 1979.
Zubler R. H., Benacerraf B., Germaine R. N.: Feedback suppression of the immune responsein vitro. II. IgVH-restricted antibody-dependent suppression — J. exp. Med.151, 681, 1980.
Zubler R. H., Cantor H., Benacerraf B., Germaine R. N.: Feedback suppression of the immune responsein vitro. I. Activity of antigen-stimulated B cells — J. exp. Med.151, 667, 1980.
Zubler R. H., Lowenthal J. W., Erard F., Hashimoto N., Devos R., McDonald H. R.: Activated B cells express receptors for and proliferate in response to pure interleukin-2 — J. exp. Med.160, 1170, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Habeshaw, J.A. The immune system and lymphoma. La Ricerca Clin. Lab. 17, 87–109 (1987). https://doi.org/10.1007/BF02909404
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02909404